241 related articles for article (PubMed ID: 36710358)
41. A novel gene signature associated with poor response to chemoradiotherapy in patients with locally advanced cervical cancer.
Kim KH; Chang JS; Byun HK; Kim YB
J Gynecol Oncol; 2022 Jan; 33(1):e7. PubMed ID: 34783210
[TBL] [Abstract][Full Text] [Related]
42. Radiochemotherapy induces a favourable tumour infiltrating inflammatory cell profile in head and neck cancer.
Tabachnyk M; Distel LV; Büttner M; Grabenbauer GG; Nkenke E; Fietkau R; Lubgan D
Oral Oncol; 2012 Jul; 48(7):594-601. PubMed ID: 22356894
[TBL] [Abstract][Full Text] [Related]
43. Changes of CD68, CD163, and PD-L1 tumor expression during high-dose-rate and pulsed-dose-rate brachytherapy for cervical cancer.
Berenguer Frances MA; Linares-Galiana I; Cañas Cortés R; Marín I Borrás S; Gutiérrez Miguélez C; Najjari D; Slocker A; Bellobí C; Santacana M; Pané Foix M; Alonso MH; Navarro-Martin A; Comas Antón S; Guedea F
Brachytherapy; 2020; 19(1):51-59. PubMed ID: 31690516
[TBL] [Abstract][Full Text] [Related]
44. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.
Abbas M; Kushwaha VS; Srivastava K; Banerjee M
PLoS One; 2015; 10(11):e0142501. PubMed ID: 26571237
[TBL] [Abstract][Full Text] [Related]
45. Aberrantly Expressed Timeless Regulates Cell Proliferation and Cisplatin Efficacy in Cervical Cancer.
Zhou J; Zhang Y; Zou X; Kuai L; Wang L; Wang J; Shen F; Hu J; Zhang X; Huang Y; Chen Y
Hum Gene Ther; 2020 Mar; 31(5-6):385-395. PubMed ID: 31870179
[TBL] [Abstract][Full Text] [Related]
46. Radiochemotherapy for patients with locally advanced cervical cancer: early results.
Ozsaran Z; Yalman D; Yürüt V; Aras A; Ozsaran A; Hanhan M; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(2):191-4. PubMed ID: 12701977
[TBL] [Abstract][Full Text] [Related]
47. MiR-200b promotes the cell proliferation and metastasis of cervical cancer by inhibiting FOXG1.
Zeng F; Xue M; Xiao T; Li Y; Xiao S; Jiang B; Ren C
Biomed Pharmacother; 2016 Apr; 79():294-301. PubMed ID: 27044840
[TBL] [Abstract][Full Text] [Related]
48. Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT.
Zhu H; Tao X; Zhou L; Sheng B; Zhu X; Zhu X
BMC Cancer; 2019 Aug; 19(1):865. PubMed ID: 31470801
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.
Kim HS; Kim CK; Park BK; Huh SJ; Kim B
J Magn Reson Imaging; 2013 Jan; 37(1):187-93. PubMed ID: 23018989
[TBL] [Abstract][Full Text] [Related]
50. [Simultaneous radiochemotherapy with cisplatin improves survival in cervical cancer].
Dunst J; Sauer R
Strahlenther Onkol; 1999 Jun; 175(6):257-8. PubMed ID: 10392165
[No Abstract] [Full Text] [Related]
51. Outcomes for Hyperthermia Combined with Concurrent Radiochemotherapy for Patients with Cervical Cancer.
Wang Y; Hong W; Che S; Zhang Y; Meng D; Shi F; Su J; Yang Y; Ma H; Liu R; Gao Y; Wang J; Hui B; Wang J; Lu J; Wang T; Liu Z; Chen H
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):499-511. PubMed ID: 32179132
[TBL] [Abstract][Full Text] [Related]
52. Combined Treatment with Autologous CIK Cells, Radiotherapy and Chemotherapy in Advanced Cervical Cancer.
Li N; Tian YW; Xu Y; Meng DD; Gao L; Shen WJ; Liu ZL; Xu ZQ
Pathol Oncol Res; 2019 Apr; 25(2):691-696. PubMed ID: 30511107
[TBL] [Abstract][Full Text] [Related]
53. Identification of prognosis-related genes in the cervical cancer immune microenvironment.
Yang L; Yang Y; Meng M; Wang W; He S; Zhao Y; Gao H; Tang W; Liu S; Lin Z; Li L; Hou Z
Gene; 2021 Jan; 766():145119. PubMed ID: 32946928
[TBL] [Abstract][Full Text] [Related]
54. Mechanism of hydrogen on cervical cancer suppression revealed by high‑throughput RNA sequencing.
Chu J; Gao J; Wang J; Li L; Chen G; Dang J; Wang Z; Jin Z; Liu X
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080660
[TBL] [Abstract][Full Text] [Related]
55. Effects of anemia correction with epoetin beta in patients receiving radiochemotherapy for advanced cervical cancer.
Strauss HG; Haensgen G; Dunst J; Hayward CR; Burger HU; Scherhag A; Koelbl H
Int J Gynecol Cancer; 2008; 18(3):515-24. PubMed ID: 17645506
[TBL] [Abstract][Full Text] [Related]
56. Breaking the DNA damage response to improve cervical cancer treatment.
Wieringa HW; van der Zee AG; de Vries EG; van Vugt MA
Cancer Treat Rev; 2016 Jan; 42():30-40. PubMed ID: 26643553
[TBL] [Abstract][Full Text] [Related]
57. Predictive role of galectin-1 and integrin α5β1 in cisplatin-based neoadjuvant chemotherapy of bulky squamous cervical cancer.
Zhu H; Chen A; Li S; Tao X; Sheng B; Chetry M; Zhu X
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28842515
[TBL] [Abstract][Full Text] [Related]
58. Radiochemotherapy versus radiotherapy in locally advanced cervical cancer: a meta-analysis.
Wang N; Guan QL; Wang K; Zhou X; Gao C; Yang HT; Ni TG
Arch Gynecol Obstet; 2011 Jan; 283(1):103-8. PubMed ID: 20157716
[TBL] [Abstract][Full Text] [Related]
59. Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: results of a companion protocol of the randomized, NOGGO-AGO phase III adjuvant trial of simultaneous cisplatin-based radiochemotherapy vs. carboplatin and paclitaxel containing sequential radiotherapy.
Braicu EI; Fotopoulou C; Chekerov R; Richter R; Blohmer J; Kümmel S; Stamatian F; Yalcinkaya I; Mentze M; Lichtenegger W; Sehouli J
Cytokine; 2013 Mar; 61(3):755-8. PubMed ID: 23415672
[TBL] [Abstract][Full Text] [Related]
60. Gene expression profiling of women with varying degrees of cervical intraepithelial neoplasia.
Kendrick JE; Conner MG; Huh WK
J Low Genit Tract Dis; 2007 Jan; 11(1):25-8. PubMed ID: 17194947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
